Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptor

Transplant Proc. 1988 Apr;20(2):300-2.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / pharmacokinetics
  • Antibodies, Monoclonal / therapeutic use*
  • Graft Rejection
  • Humans
  • Immunosuppression Therapy
  • Interleukin-2 / physiology*
  • Kidney Transplantation*
  • Receptors, Immunologic / immunology*
  • Receptors, Interleukin-2

Substances

  • Antibodies, Monoclonal
  • Interleukin-2
  • Receptors, Immunologic
  • Receptors, Interleukin-2